Participation in Clinical Research Registries: A Focus Group Study Examining Views From Patients With Arthritis and Other Chronic Illnesses

Arthritis Care and Research

Volumn 68, Issue 7, 2016, Pages 974-980

  Lee, Sara B ^a   Zak, Agnes ^a   Iversen, Maura D ^b   Polletta, Valerie L ^c   Shadick, Nancy A ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c Health Resources in Action ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTRUISM; ARTHRITIS; ARTICLE; ATTITUDE TO HEALTH; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL RESEARCH; CONFIDENTIALITY; COOPERATION; ENGLISHMAN; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MOTIVATION; OSTEOARTHRITIS; PATIENT PARTICIPATION; PERSONAL EXPERIENCE; QUALITY OF LIFE; RESEARCH SUBJECT; RHEUMATOID ARTHRITIS; SPANIARD; TRUST;

EID: 84976562903     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22767     Document Type: Article

References (28)

1. Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis 2014;11:E62.
2. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013;61:1–117.
3. Anderson G. Chronic care: making the case for ongoing care. Princeton (NJ): Robert Wood Johnson Foundation; 2010.
4. Gliklich R, Dreyer N, eds. Registries for evaluating patient outcomes: a user’s guide. Rockville (MD): Agency for Healthcare Research and Quality; 2007.
5. Chodick G, Heymann AD, Shalev V, Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol 2003;18:1143–6.
6. Carney PA, Poplack SP, Wells WA, Littenberg B. The New Hampshire Mammography Network: the development and design of a population-based registry. AJR Am J Roentgenol 1996;167:367–72.
7. Iannaccone CK, Lee YC, Cui J, Frits ML, Glass RJ, Plenge RM, et al. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women’s Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford) 2011;50:40–6.
8. Mikuls TR, Fay BT, Michaud K, Sayles H, Thiele GM, Caplan L, et al. Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry. Rheumatology (Oxford) 2011;50:101–9.
9. Saeki Y, Matsui T, Saisho K, Tohma S. Current treatments of rheumatoid arthritis: from the “NinJa” registry. Expert Rev Clin Immunol 2012;8:455–65.
10. US Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. 2009. URL: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
11. Patient-Centered Outcomes Research Institute. PCORI methodology standards. Washington (DC): Patient-Centered Outcomes Research Institute; 2012.
12. Hewlett SA. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 2003;30:877–9.
13. Geppert C, Candilis P, Baker S, Lidz C, Appelbaum P, Fletcher K. Motivations of patients with diabetes to participate in research. AJOB Empir Bioeth 2014;5:14–21.
14. Linden HM, Reisch LM, Hart A Jr, Harrington MA, Nakano C, Jackson JC, et al. Attitudes toward participation in breast cancer randomized clinical trials in the African American community: a focus group study. Cancer Nurs 2007;30:261–9.
15. Schneider J, Vuckovic N, DeBar L. Willingness to participate in complementary and alternative medicine clinical trials among patients with craniofacial disorders. J Altern Complement Med 2003;9:389–401.
16. Townsley CA, Chan KK, Pond GR, Marquez C, Siu LL, Straus SE. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer 2006;6:34.
17. Korngut L, MacKean G, Casselman L, Johnston M, Day L, Lam D, et al. Perspectives on neurological patient registries: a literature review and focus group study. BMC Med Res Methodol 2013;13:135.
18. Strauss A, Corbin JM. Basics of qualitative research: grounded theory, procedures and techniques. Los Angeles: Sage Publications; 1990.
19. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999;52:1143–56.
20. Jefferson AL, Lambe S, Chaisson C, Palmisano J, Horvath KJ, Karlawish J. Clinical research participation among aging adults enrolled in an Alzheimer’s Disease Center research registry. J Alzheimers Dis 2011;23:443–52.
21. Robiner WN, Yozwiak JA, Bearman DL, Strand TD, Strasburg KR. Barriers to clinical research participation in a diabetes randomized clinical trial. Soc Sci Med 2009;68:1069–74.
22. Roberson NL. Clinical trial participation: viewpoints from racial/ethnic groups. Cancer 1994;74 Suppl:2687–91.
23. Shavers VL, Lynch CF, Burmeister LF. Factors that influence African-Americans’ willingness to participate in medical research studies. Cancer 2001;91 Suppl:233–6.
24. Anwuri VV, Hall LE, Mathews K, Springer BC, Tappenden JR, Farria DM, et al. An institutional strategy to increase minority recruitment to therapeutic trials. Cancer Causes Control 2013;24:1797–809.
25. Ashing-Giwa K, Rosales M. Recruitment and retention strategies of African American and Latina American breast cancer survivors in a longitudinal psycho-oncology study. Oncol Nurs Forum 2012;39:E434–42.
26. Dreer LE, Weston J, Owsley C. Strategic planning for recruitment and retention of older African Americans in health promotion research programs. J Health Dispar Res Pract 2014;7:14–33.
27. Stewart DW, Shamdasani PM. Focus groups: theory and practice. London: Sage Publications; 1990.
28. Tang KC, Davis A. Critical factors in the determination of focus group size. Fam Pract 1995;12:474–5.